23 Jul, 2026
According to Straits Research, the global mRNA synthesis raw material market size was valued at $1.71 billion in 2025 and is projected to grow from $1.81 billion in 2026 to $2.83 billion by 2034, registering a CAGR of 5.78% during the forecast period 2026–2034.
The mRNA synthesis raw material market is gaining traction as global research and development efforts increasingly adopt mRNA platforms for vaccines, therapeutics and advanced molecular studies. A key driver supporting market expansion is the rising integration of precision RNA technologies across diverse therapeutic areas, which requires a steady supply of specialized nucleotides, capping agents, and high-performance enzymes to maintain consistent transcription quality. As developers advance toward customizable mRNA constructs tailored for disease-specific interventions, material demand broadens across both clinical and preclinical environments. However, a notable restraint arises from fluctuations in international supply chains for temperature-sensitive reagents. Variability in cold chain logistics and potential shipment delays introduce procurement challenges for organizations that rely on uninterrupted access to transcription-grade materials for sequential production cycles. These constraints can affect planning timelines for research groups and manufacturing facilities working on rapid turnaround projects. Despite these challenges, the market presents a substantial opportunity driven by the expansion of decentralized RNA production frameworks across academic clusters, contract service organizations, and emerging biomanufacturing hubs. As institutions establish modular RNA synthesis units to support local vaccine development, therapeutics engineering, and diagnostic design, demand increases for scalable raw material packages compatible with varied production capacities. This shift encourages broader supplier participation and accelerates the development of diversified reagent portfolios to meet evolving project requirements across regional and global markets.
sales@straitsresearch.com